These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21609346

  • 1. Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours.
    Stobo DB, Lindsay RS, Connell JM, Dunn L, Forbes KP.
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):673-7. PubMed ID: 21609346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y, Grober H, Wintermark M, Jane JA, Oldfield EH.
    J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
    [Abstract] [Full Text] [Related]

  • 4. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM, Albiger N, Occhi G, Sanguin F, Scanarini M, Berlucchi S, Gardiman MP, Carollo C, Mantero F, Scaroni C.
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pituitary magnetic resonance imaging in Cushing's disease.
    Vitale G, Tortora F, Baldelli R, Cocchiara F, Paragliola RM, Sbardella E, Simeoli C, Caranci F, Pivonello R, Colao A, A.B.C. Group.
    Endocrine; 2017 Mar; 55(3):691-696. PubMed ID: 27435590
    [Abstract] [Full Text] [Related]

  • 8. A modified protocol using half-dose gadolinium in dynamic 3-Tesla magnetic resonance imaging for detection of ACTH-secreting pituitary tumors.
    Portocarrero-Ortiz L, Bonifacio-Delgadillo D, Sotomayor-González A, Garcia-Marquez A, Lopez-Serna R.
    Pituitary; 2010 Sep; 13(3):230-5. PubMed ID: 20182808
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Imaging of gliomas at 1.5 and 3 Tesla - A comparative study.
    Tselikas L, Souillard-Scemama R, Naggara O, Mellerio C, Varlet P, Dezamis E, Domont J, Dhermain F, Devaux B, Chrétien F, Meder JF, Pallud J, Oppenheim C.
    Neuro Oncol; 2015 Jun; 17(6):895-900. PubMed ID: 25526734
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
    Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.
    Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
    [Abstract] [Full Text] [Related]

  • 17. Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.
    Guarnaschelli JN, Vagal AS, McKenzie JT, McPherson CM, Warnick RE, Batra V, Breneman JC, Lamba MA.
    Pract Radiat Oncol; 2014 Jun; 4(5):e195-e201. PubMed ID: 25194105
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.